🐦 推特Wall St EngineCodex · 实盘不做把握 5/10
北京时间·🕒 发布 18:10:50时区推断·⟳ 抓取 18:10:55·⚡ 决策 07-16 18:15:19 +4m24s·103.0 天前
联合健康二季度业绩大幅好于预期并上调全年指引
二季度调整后EPS 6.38美元显著高于市场预期4.85美元，全年调整后EPS指引上调至19.50-20.00美元，高于约18.32美元一致预期。
📄 原文Wall St Engine@wallstengine↗ 原文
UNITEDHEALTH GROUP $UNH Q2’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $112.0B (Est. $110.8B) 🟢; flat YoY 🔹 Adj. EPS: $6.38 (Est.…
不做 UnitedHealth Group（UNH.US）
财报方向偏利多但属于可预期日历事件，UNH体量大且同主体近三次财报后+3日胜率为0%，盘前无可成交确认价，开盘追多正期望不足，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-16 · 扩散 medium · price-in 风险 medium ↗
消息传播链
- 盘前发布UNH二季度业绩摘要，EPS、MCR、经营利润和全年指引均好于预期。市场反应:当时美股常规交易未开盘，行情工具未给出可用于成交的盘前价。
关键理由
- 二季度调整后EPS 6.38美元显著高于市场预期4.85美元，全年调整后EPS指引上调至19.50-20.00美元，高于约18.32美元一致预期。
- MCR 86.7%低于预期88.6%，UnitedHealthcare和Optum经营利润均明显好于预期，说明医疗成本压力短期缓和。
- 但UNH为约3800亿美元市值巨头，财报属于日历型明牌事件，历史同类财报后+3日胜率为0%，追开盘正期望不足。
主要风险
- 近期UNH同类财报即使超预期也多次高开后走弱或继续下跌，存在明显sell-the-news风险。
- 监管、医疗成本趋势和医保报销政策仍是核心反向风险，单季MCR改善未必足以触发持续重估。
反向证据
- 做多前查反向 · 来源 web · 影响 weakens
UNH核心反向风险仍集中在监管、医保报销和医疗成本趋势，单季MCR改善可能被视作阶段性修复而非新周期。
检索:UnitedHealth regulatory investigation medical cost pressure Medicare Advantage 2026 risk - 做多前查反向 · 来源 event_study · 日期 2026-07-16 · 影响 weakens
同主体近三次财报相位样本的+3日胜率为0%，追财报开盘缺乏历史支持。
检索:UNH earnings beat guidance raise historical post earnings stock reaction
历史先例(按相似度)
- UNH 2025-10-28 Q3 2025 EPS和收入超预期、MCR低于预期并小幅上调2025 EPS指引，事件日盘中高开后回落。 原文 ↗
测UNH在2025-10-28财报后+1/+3/+5日反应：-3.42%/-7.14%/-10.06%。 - UNH 2025-07-29 Q2 2025低于预期且全年指引疲弱，作为同主体财报风险对照样本。 原文 ↗
测UNH在2025-07-29财报后+1/+3/+5日反应：+1.90%/-8.92%/-3.86%。 - UNH 2026-05-14 Q1 2026 EPS明显超预期并上调全年指引，但后续股价未延续上涨。 原文 ↗
测UNH在2026-05-14财报后+1/+3/+5日反应：-1.31%/-2.47%/-4.16%。
工具调用 · 历史记录,结果未知(2 种)
- stock_quote · 结果未知
- event_study · 结果未知
原文全文
展开原文 · 1,278 字
UNITEDHEALTH GROUP $UNH Q2’26 EARNINGS HIGHLIGHTS
🔹 Revenue: $112.0B (Est. $110.8B) 🟢; flat YoY
🔹 Adj. EPS: $6.38 (Est. $4.85) 🟢; +56% YoY
🔹 MCR: 86.7% (Est. 88.6%) 🟢; -270 bps YoY
🔹 UnitedHealthcare OI: $3.9B; +86% YoY (Est. +40.7% YoY) 🟢
Raises FY26 Guide:
🔹 Adj. EPS: $19.50-$20.00 (Est ~$18.32) 🟢
🔹 EPS: $18.45-$18.95 (Prior: >$17.10)
🔹 Operating Earnings: >$25.45B (Prior: >$24.0B)
🔹 Net Earnings: >$16.75B (Prior: >$15.60B)
🔹 UnitedHealthcare Op. Earnings: >$12.0B (Prior: >$10.8B)
🔹 Optum Op. Earnings: >$13.45B (Prior: >$13.2B)
🔹 Medical Care Ratio: 88.1% ±25 bps (Prior: 88.8% ±50 bps)
🔹 Operating Cash Flow: ~$24.0B (Prior: >$18.0B)
🔹 Share Repurchases: ≥$5.0B (Prior: ~$2.5B)
Segment Net Revenue:
🔹 UnitedHealthcare: $86.0B; flat YoY
🔹 Optum: $65.7B; -2% YoY
Other Q2 Metrics:
🔹 Optum Op Income: $4.0B; +29% YoY (Est. +7.8% YoY) 🟢
🔹 Earnings from Operations: $8.0B; +54% YoY
🔹 Operating Cost Ratio: 12.7%; +40 bps YoY
🔹 Net Margin: 4.9%; +180 bps YoY
🔹 Cash Flows from Operations: $11.1B
Comments:
🔸 “Our results and outlook reflect the continuing progress in our work to simplify how we operate, improve both affordability and the health care experience for patients and care providers and apply modern technology to create real improvement for people.”
🔹 Revenue: $112.0B (Est. $110.8B) 🟢; flat YoY
🔹 Adj. EPS: $6.38 (Est. $4.85) 🟢; +56% YoY
🔹 MCR: 86.7% (Est. 88.6%) 🟢; -270 bps YoY
🔹 UnitedHealthcare OI: $3.9B; +86% YoY (Est. +40.7% YoY) 🟢
Raises FY26 Guide:
🔹 Adj. EPS: $19.50-$20.00 (Est ~$18.32) 🟢
🔹 EPS: $18.45-$18.95 (Prior: >$17.10)
🔹 Operating Earnings: >$25.45B (Prior: >$24.0B)
🔹 Net Earnings: >$16.75B (Prior: >$15.60B)
🔹 UnitedHealthcare Op. Earnings: >$12.0B (Prior: >$10.8B)
🔹 Optum Op. Earnings: >$13.45B (Prior: >$13.2B)
🔹 Medical Care Ratio: 88.1% ±25 bps (Prior: 88.8% ±50 bps)
🔹 Operating Cash Flow: ~$24.0B (Prior: >$18.0B)
🔹 Share Repurchases: ≥$5.0B (Prior: ~$2.5B)
Segment Net Revenue:
🔹 UnitedHealthcare: $86.0B; flat YoY
🔹 Optum: $65.7B; -2% YoY
Other Q2 Metrics:
🔹 Optum Op Income: $4.0B; +29% YoY (Est. +7.8% YoY) 🟢
🔹 Earnings from Operations: $8.0B; +54% YoY
🔹 Operating Cost Ratio: 12.7%; +40 bps YoY
🔹 Net Margin: 4.9%; +180 bps YoY
🔹 Cash Flows from Operations: $11.1B
Comments:
🔸 “Our results and outlook reflect the continuing progress in our work to simplify how we operate, improve both affordability and the health care experience for patients and care providers and apply modern technology to create real improvement for people.”
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。